Huntington

Huntington is a biotechnology company that develops gene therapies for neurological diseases, including a treatment for Huntington's disease.

Why it’s in the news: It is in the news due to its ongoing clinical trials for a Huntington's gene therapy and a lawsuit filed against several companies over a significant debt.

Latest on Huntington

• STAT+: Why a Huntington’s patient isn’t fazed by the waning effect of UniQure’s gene therapy
• STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years
• Huntington sues 24 R&R companies over more than $12M in debt
• STAT+: What to expect from UniQure’s upcoming Huntington’s gene therapy readout
• STAT+: Pharmalittle: We’re reading about a Huntington’s gene therapy, Novo’s challenges, and more
• STAT+: Roche ends Huntington’s gene-silencing programs

Connections

9 entities linked to Huntington across the news graph.